These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

The Trump administration’s cuts to university research grants will make America sicker and poorer in the long run.

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

At medical conferences and hospital cafeterias, one thing has become increasingly clear—many doctors are using Ozempic, ...

Jim Cramer, the host of Mad Money, recently took a deep dive into the challenges facing the consumer packaged goods sector, ...

Hershey's current stock decline is due to high cocoa prices, but historical trends suggest recovery once prices normalize.

US bakery major Flowers Foods has blamed ongoing bread category weakness and changing consumer preferences for ...

Insurers also ask the Trump administration, which is engaged in a sweeping campaign to eradicate anything related to ...